Shenzhen-based humanoid robot maker LimX Dynamics has closed a pre-IPO funding round of nearly $200 million, the company announced on July 14, valuing it at roughly 15 billion yuan (about $2.1 billion). The round brings LimX’s total funding over the past six months to roughly $400 million, following a $200 million Series B round in February.
New backers in the round include IDG Capital, Apple supplier Lens Technology, Italy’s GGG Group, Germany’s Redstone VC, Hua Capital, and the Hefei Binhu Industrial Development Group, alongside Abu Dhabi-based Stone Venture, which has now invested across multiple rounds. Existing shareholders — including Oasis Capital, Jizhi Capital, Nanshan Strategic Emerging Industry Investment, Shangqi Capital and Nio Capital — also added to their stakes, the company said.
LimX said the money will fund further work on what it calls “brain-cerebellum” control technology — a three-layer software stack pairing a full-body motion foundation model with a vision-language-action system and an embodied-agent operating system called COSA — as well as scaling production of its humanoid robots and expanding into overseas markets across the Middle East, Europe and Asia.
Founded in 2022, LimX builds a line of humanoid robots, including the 160-centimeter, 27-degree-of-freedom Luna launched in May, the general-purpose Oli, and the TRON series of research and industrial robots. The company says it has booked orders for thousands of units, with more than half coming from customers outside China.
Part of a broader IPO push
LimX has completed a share reform and formally begun the IPO process, according to the company, positioning it among a wave of Chinese humanoid-robot makers racing toward public markets. Unitree Robotics recently won approval for a roughly $620 million Shanghai listing, while Toyota-backed Walden Robotics took a different route, emerging from stealth with a $1.1 billion valuation.
The funding underscores how capital is concentrating in a handful of well-financed robotics startups as China’s humanoid-robot industry moves from prototypes toward commercial deployment, backed by both state and private investors betting on hardware built for Chinese factories and beyond.